Abstraction Health

Vitamin C

Water-Soluble Vitamin

Also known as: Ascorbic acid · Ascorbate · L-ascorbic acid

🟢Strong Evidence 203 expert mentions 20 studies
C·61/100·Fair
Research Depth25/25
Study Quality9/25
Expert Consensus23/25
Claim Support4/25
How we score the evidence →

An essential water-soluble vitamin and antioxidant. Critical for collagen synthesis, immune function, and neurotransmitter production. Widely studied at doses well above the RDA.

Common forms:ascorbic acidsodium ascorbateliposomal vitamin C

The bottom line

For most healthy people eating a normal diet, extra vitamin C does less than its immune-boosting reputation suggests — the stronger evidence is in specific situations (collagen synthesis, certain pain conditions), while the broad 'prevents colds, boosts immunity' claims are largely unsupported here. It's cheap and safe up to ~1,000 mg/day, so the main downside of trying it is your money. Skip the megadoses if you're prone to kidney stones or have hemochromatosis.

Our plain-language reading of the expert claims and research on this page. Not medical advice.

How expert claims hold up

193 of 203 claims assessed
29Partial164Insufficient10Pending

29 of 193 assessed claims supported or partially supported by published research

Expert Consensus

Universal consensusPartially supported
4/5
Experts mention
4
Recommend
2
Flag caution
Andrew Huberman
Andrew Huberman Recommends Caution
Partially supported96 claims5000-10000milligrams or 5-10grams or 75-90milligrams or 500-1000milligrams or 500milligramsintravenousoral
Rhonda Patrick
Rhonda Patrick Recommends
Partially supported82 claims200milligrams or 500–1000milligramsfood and supplementationoralfood and supplement combination
Mark Hyman
Mark Hyman Recommends
Partially supported20 claims60milligrams
David Sinclair
David Sinclair Recommends Caution
Partially supported5 claimsgreens powder drink

Dose divergence: Experts recommend different amounts (5000-10000milligrams, 5-10grams, 75-90milligrams, 500-1000milligrams, 500milligrams, 200milligrams, 500–1000milligrams, 60milligrams). Check the Stack & Timing tab for study-backed dosing ranges.

Evidence Summary

PubMed / NCBI·May 2026
All 20 studies
20
Studies
10
RCTs
4
Reviews

The available research on vitamin C supplementation spans several health domains, including skin health, immune function, pain management, stress response, collagen synthesis, and cardiovascular health. Across 15 studies — including multiple meta-analyses, systematic reviews, and randomized controlled trials (RCTs) — vitamin C shows meaningful benefits in specific, well-defined contexts, though the overall evidence base is uneven in quality and scope. The majority of expert claims reviewed (roughly 78%) were rated as having insufficient evidence support, suggesting that popular claims about vitamin C frequently outpace what the current literature can firmly establish.

Read full evidence summary →

Top studies

Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment: JACC Focus Seminar.

Journal of the American College of Cardiology · 2021 · Jenkins DJA et al.
Meta-Analysis🟢
Key finding

Supplemental Vitamins and Minerals for Cardiovascular Disease Prevention and Treatment: JACC Focus Seminar.

Funded by: CIHR
COI: Author Disclosures This work is supported by the Canada Research Chair Endowment, Loblaw Cos. Ltd., and Canadian Institutes for Health Research (CIHR). Dr. Jenkins is funded by the government of Canada through the Canada Research Chair Endowment; has previously (more than 4 years ago) received funds for dietary studies from Loblaws, which during the course of his funding acquired Shopper’s Drugmart, which is a drug store chain that also sells supplements; has received research grants from Saskatchewan & Alberta Pulse Growers Associations, the Agricultural Bioproducts Innovation Program through the Pulse Research Network, the Advanced Foods and Material Network, Loblaw Companies Ltd., Unilever Canada and Netherlands, Barilla, the Almond Board of California, Agriculture and Agri-food Canada, Pulse Canada, Kellogg's Company, Quaker Oats, Procter & Gamble Technical Centre Ltd., Bayer Consumer Care, Pepsi/Quaker, International Nut & Dried Fruit (INC), Soy Foods Association of North America, the Coca-Cola Company (investigator initiated, unrestricted grant), Solae, Haine Celestial, the Sanitarium Company, Orafti, the International Tree Nut Council Nutrition Research and Education Foundation, the Peanut Institute, Soy Nutrition Institute, the Canola and Flax Councils of Canada, the Calorie Control Council, the Canadian Institutes of Health Research, the Canada Foundation for Innovation, and the Ontario Research Fund; has received in-kind supplies for trials as a research support from the Almond Board of California, Walnut Council of California, American Peanut Council, Barilla, Unilever, Unico, Primo, Loblaw Companies, Quaker (Pepsico), Pristine Gourmet, Bunge Limited, Kellogg Canada, and WhiteWave Foods; has been on the speaker's panel, served on the scientific advisory board of, and/or received travel support and/or honoraria from the Almond Board of California, Canadian Agriculture Policy Institute, Loblaw Companies Ltd., the Griffin Hospital (for the development of the NuVal scoring system), the Coca-Cola Company, EPICURE, Danone, Diet Quality Photo Navigation, Better Therapeutics (FareWell), Verywell, True Health Initiative, Heali AI Corp, Institute of Food Technologists, Soy Nutrition Institute, Herbalife Nutrition Institute, Saskatchewan & Alberta Pulse Growers Associations, Sanitarium Company, Orafti, the American Peanut Council, the International Tree Nut Council Nutrition Research and Education Foundation, the Peanut Institute, Herbalife International, Pacific Health Laboratories, Nutritional Fundamentals for Health, Barilla, Metagenics, Bayer Consumer Care, Unilever Canada and Netherlands, Solae, Kellogg, Quaker Oats, Procter & Gamble, Abbott Laboratories, Dean Foods, the California Strawberry Commission, Haine Celestial, PepsiCo, the Alpro Foundation, Pioneer Hi-Bred International, DuPont Nutrition and Health, Spherix Consulting and WhiteWave Foods, the Advanced Foods and Material Network, the Canola and Flax Councils of Canada, Agri-Culture and Agri-Food Canada, the Canadian Agri-Food Policy Institute, Pulse Canada, the Soy Foods Association of North America, the Nutrition Foundation of Italy, Nutra-Source Diagnostics, the McDougall Program, the Toronto Knowledge Translation Group (St. Michael's Hospital), the Canadian College of Naturopathic Medicine, The Hospital for Sick Children, the Canadian Nutrition Society, the American Society of Nutrition, Arizona State University, Paolo Sorbini Foundation, and the Institute of Nutrition, Metabolism and Diabetes; has received an honorarium from the United States Department of Agriculture to present the 2013 W.O. Atwater Memorial Lecture; has received the 2013 Award for Excellence in Research from the International Nut and Dried Fruit Council; has received funding and travel support from the Canadian Society of Endocrinology and Metabolism to produce mini cases for the Canadian Diabetes Association; has served as a member of the International Carbohydrate Quality Consortium (ICQC); his wife, Alexandra L. Jenkins, is a director and partner of INQUIS Clinical Research for the Food Industry; his 2 daughters, Wendy Jenkins and Amy Jenkins, have published a vegetarian book that promotes the use of the foods described here, The Portfolio Diet for Cardiovascular Risk Reduction (Academic Press/Elsevier 2020 ISBN:978-0-12-810510-8); and his sister, Caroline Brydson, received funding through a grant from the St. Michael's Hospital Foundation to develop a cookbook for one of his studies. Dr. Spence has served as an unpaid officer of Vascularis Inc.; and has served as a consultant to Amgen and Orphan Technologies. Dr. Josse has served as a member of the Bone Medical Advisory Board of Amgen; and has received honoraria for lectures from Amgen. Dr. Viguiliouk has served as scientific advisor for New Era Nutrition. Dr. Nishi was an employee at GI Labs (now INQUIS Clinical Research, Inc.), a contract research organization from 2014 to 2016; and is currently employed part-time by the Diabetes Heart Research Centre coordinating trials sponsored by Novo Nordisk, Sanofi, AstraZeneca, Eli Lilly, Lexicom, and Boehringer Ingelheim. Dr. Kendall has received grants or research support from the Advanced Food Materials Network, Agriculture and Agri-Foods Canada, Almond Board of California, American Peanut Council, Barilla, Canadian Institutes of Health Research, Canola Council of Canada, International Nut and Dried Fruit Council, International Tree Nut Council Research and Education Foundation, Loblaw Brands Ltd, Pulse Canada, and Unilever; has received in-kind research support from the Almond Board of California, American Peanut Council, Barilla, California Walnut Commission, Kellogg Canada, Loblaw Companies, Quaker (PepsiCo), Primo, Unico, Unilever, and WhiteWave Foods/Danone; has received travel support and/or honoraria from the American Peanut Council, Barilla, California Walnut Commission, Canola Council of Canada, General Mills, International Nut and Dried Fruit Council, International Pasta Organization, Loblaw Brands Ltd, Nutrition Foundation of Italy, Oldways Preservation Trust, Paramount Farms, Peanut Institute, Pulse Canada, Sun-Maid, Tate & Lyle, Unilever and White Wave Foods/Danone; has served on the scientific advisory board for the International Tree Nut Council, International Pasta Organization, McCormick Science Institute and Oldways Preservation Trust; has served as a member of the International Carbohydrate Quality Consortium, Executive Board Member of the Diabetes and Nutrition Study Group of the European Association for the Study of Diabetes; is on the Clinical Practice Guidelines Expert Committee for Nutrition Therapy of the European Association for the Study of Diabetes; and is a Director of the Toronto 3D Knowledge Synthesis and Clinical Trials foundation. Dr. Sievenpiper has received research support from the Canadian Foundation for Innovation, Ontario Research Fund, Province of Ontario Ministry of Research and Innovation and Science, Canadian Institutes of Health Research (CIHR), Diabetes Canada, PSI Foundation, Banting and Best Diabetes Centre (BBDC), American Society for Nutrition (ASN), INC International Nut and Dried Fruit Council Foundation, National Dried Fruit Trade Association, National Honey Board, International Life Sciences Institute (ILSI), Pulse Canada, Quaker, The Tate and Lyle Nutritional Research Fund at the University of Toronto, The Glycemic Control and Cardiovascular Disease in Type 2 Diabetes Fund at the University of Toronto (a fund established by the Alberta Pulse Growers), and the Nutrition Trialists Fund at the University of Toronto (a fund established by an inaugural donation from the Calorie Control Council); has received in-kind food donations to support a randomized controlled trial from the Almond Board of California, California Walnut Commission, American Peanut Council, Barilla, Unilever, Upfield, Unico/Primo, Loblaw Companies, Quaker, Kellogg Canada, WhiteWave Foods, and Nutrartis; has received travel support, speaker fees and/or honoraria from Diabetes Canada, Dairy Farmers of Canada, FoodMinds LLC, International Sweeteners Association, Nestlé, Pulse Canada, Canadian Society for Endocrinology and Metabolism (CSEM), GI Foundation, Abbott, General Mills, Biofortis, ASN, Northern Ontario School of Medicine, INC Nutrition Research & Education Foundation, European Food Safety Authority (EFSA), Comité Européen des Fabricants de Sucre (CEFS), and Physicians Committee for Responsible Medicine; has or has had ad hoc consulting arrangements with Perkins Coie LLP, Tate & Lyle, Wirtschaftliche Vereinigung Zucker e.V., Danone, and Inquis Clinical Research; is a member of the European Fruit Juice Association Scientific Expert Panel and Soy Nutrition Institute (SNI) Scientific Advisory Committee; is on the Clinical Practice Guidelines Expert Committees of Diabetes Canada, European Association for the study of Diabetes (EASD), Canadian Cardiovascular Society (CCS), and Obesity Canada; serves or has served as an unpaid scientific advisor for the Food, Nutrition, and Safety Program (FNSP) and the Technical Committee on Carbohydrates of ILSI North America; is a member of the International Carbohydrate Quality Consortium (ICQC), Executive Board Member of the Diabetes and Nutrition Study Group (DNSG) of the EASD, and Director of the Toronto 3D Knowledge Synthesis and Clinical Trials foundation; and his wife is an employee of AB InBev. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
PMID: 33509399DOI: 10.1016/j.jacc.2020.09.619
View on PubMed

Efficacy of vitamin C supplementation in preventing and treating complex regional pain syndrome type I (CRPS-I) in Orthopedic patients: A systematic review and meta-analysis.

International journal of orthopaedic and trauma nursing · 2024 · Ranjbar Moghaddam M et al.
Meta-Analysis🟢
Key finding

Efficacy of vitamin C supplementation in preventing and treating complex regional pain syndrome type I (CRPS-I) in Orthopedic patients: A systematic review and meta-analysis.

COI: Declaration of competing interest All authors do not have any actual or potential conflict of interest.
PMID: 39447383DOI: 10.1016/j.ijotn.2024.101140
View on PubMed

Expert Mentions

All 203 mentions
Andrew Huberman
Andrew Huberman
Stanford School of Medicine / Huberman Lab
Caution / warning

High-dose intravenous vitamin C has been studied for cancer and sepsis, but I want to be clear those are very different contexts from supplementation for general health.

Extracted claim

High-dose intravenous vitamin C has been studied for cancer and sepsis, but these contexts are very different from supplementation for general health.

intravenous📍 studied for cancer and sepsis; distinguished from general health supplementation
Insufficient evidence to assessHigh confidence

None of the 10 studies in the provided literature focus on high-dose intravenous vitamin C for cancer or sepsis, which are the specific contexts Huberman references. The available studies address oral…

David Sinclair
David Sinclair
Harvard Medical School
Caution / warning

are not going to hurt you unless you take mega doses...on these antioxidants, vitamin C, vitamin E, don't overdo it.

Extracted claim

Antioxidants like vitamin C will not hurt you unless you take mega doses, but you should not overdo it.

Partially supportedMedium confidence

The claim that vitamin C is generally safe but should not be taken in mega doses is broadly consistent with the research provided, though the studies above do not directly address toxicity or upper sa…

Safety, interactions & who should avoid Vitamin C

generally_recognized_safe

Vitamin C is generally considered safe at commonly used supplemental doses, and no serious adverse events were highlighted across the studies reviewed. Higher doses have theoretical risks (e.g., gastrointestinal discomfort, kidney stone formation), but these were not a primary focus of the studies in this evidence set.

Vitamin C is generally considered safe at doses up to 1000 mg/day for most healthy adults. High oral doses (above 1–2 g per dose) are associated with gastrointestinal side effects such as diarrhea and stomach cramping; bioavailability also drops markedly at these levels. Long-term mega-dosing is not well supported by the reviewed evidence.

Who should avoid it

Individuals with a history of kidney stones (particularly calcium oxalate stones) or kidney disease should use caution with supplemental vitamin C beyond dietary levels, as high doses can increase urinary oxalate excretion. Those with hemochromatosis should avoid supplemental vitamin C due to enhanced iron absorption risk.

Known interactions

  • ·May enhance iron absorption — caution in individuals with hemochromatosis or iron overload conditions
  • ·High-dose vitamin C may interfere with certain chemotherapy agents — consult a physician if undergoing cancer treatment
  • ·May affect accuracy of blood glucose monitoring at very high doses

Pregnancy & breastfeeding

We don’t assign pregnancy-safety ratings. Many supplements lack adequate safety data in pregnancy and breastfeeding, and the absence of a warning here does not mean a supplement is safe to take. Don’t start, stop, or continue any supplement while pregnant or nursing without your OB-GYN or midwife.

Read: Supplements during pregnancy & breastfeeding →

This is educational information only. Consult a healthcare provider before starting any supplement.

Stay on top of Vitamin C research

One email a month when new research on Vitamin C is published.

Double opt-in · unsubscribe anytime · not medical advice.

No buy link — yet

We only link products that meet our sourcing standards. We haven’t linked one for Vitamin C yet. Our standards →

Key findings

  • ·Vitamin C plays a well-established biochemical role as a cofactor in collagen synthesis, and RCT evidence supports that vitamin C-enriched gelatin supplementation before intermittent activity augments collagen production, with additional research suggesting collagen plus vitamin C supplementation increases lower limb rate of force development.
  • ·Meta-analyses and systematic reviews provide moderate-to-strong evidence that vitamin C supplementation may reduce pain in specific conditions, including complex regional pain syndrome type I (CRPS-I) in orthopedic patients and endometriosis-related pain, though effect sizes and clinical significance vary.
  • ·A moderate-quality RCT found that vitamin C supplementation was associated with improvements in mental vitality in healthy young adults, and a separate RCT suggested it may help alleviate elevated cortisol caused by chronic stress, pointing to potential benefits for psychological and stress-related outcomes.

Evidence gaps

  • ·The optimal daily dose of vitamin C for healthy adults remains unresolved in the literature provided — claims that 500–1000 mg/day is superior to the RDA (~75–90 mg) are only partially supported by indirect evidence, with no head-to-head dose-comparison RCTs represented in this evidence set.
  • ·Most studies in this review involved specific populations (e.g., orthopedic patients, women with endometriosis, older adults) or targeted health outcomes, making it difficult to generalize findings to healthy adults supplementing vitamin C for general wellness.
  • ·The long-term safety and efficacy of sustained higher-dose vitamin C supplementation (above 500 mg/day) in diverse, healthy populations is not well characterized by the studies provided, leaving questions about chronic use, kidney stone risk at higher doses, and interaction effects largely unanswered.